Saturday, April 08, 2006
Raising Money to Treat the World's Sickest People Isn't the Problem: Spending It Is (Vioxx danger)
Raising Money to Treat the World's Sickest People Isn't the Problem: Spending It Is
In the debate over how to build better models to help the world's neediest citizens, supporters of for-profit social-impact organizations argue that their model is more sustainable than non-profit schemes. Non-profit and foundation executives agree that new paradigms are necessary, but caution that for-profit models could ultimately put profit ahead of serving the poor. The issues surrounding
Source: knowledge.wharton.upenn.edu
Jury hears closing arguments in Vioxx trial
ATLANTIC CITY (Reuters) - Merck & Co.'s MRK.N attorney told jurors on Monday that pre-existing health problems and not Vioxx caused the heart attacks of two men suing the drugmaker, while a lawyer for one of the plaintiffs said the company deliberately hid the drug's heart risks.
Source: go.reuters.com
Jury hears closing arguments in Vioxx trial
Merck & Co.'s attorney told jurors on Monday that pre-existing health problems and not Vioxx caused the heart attacks of two men suing the drugmaker, while a lawyer for one of the plaintiffs said the company deliberately hid the drug's heart risks.
Source: news.yahoo.com
Early, Unproven Findings Changing Doctors' Practice
TUESDAY, March 14 (HealthDay News) -- Too many American doctors are jumping the gun when it comes to how they treat patients -- switching to new, largely unproven therapies on which there is only early, incomplete data.
Source: news.yahoo.com